DTRA Seeks Next Generation Sequencing for Biothreat Agents
The Defense Threat Reduction Agency (DTRA) has issued a Request for Information to identify sources with the capability to amplify, ...
The Defense Threat Reduction Agency (DTRA) has issued a Request for Information to identify sources with the capability to amplify, ...
The Defense Threat Reduction Agency (DTRA) this week announced Luminex Corp., Austin, Texas, was selected over 55 other proposals and ...
The Defense Threat Reduction Agency this week announced a new Broad Agency Announcement (BAA) amendment to solicit research proposals for ...
The Defense Threat Reduction Agency (DTRA) yesterday announced intentions to award a sole-source contract to TDA Research, Inc. to evaluate ...
The Department of Homeland Security (DHS) weighed in last week during testimony to the Senate on the agency’s activities to ...
The Department of Defense (DoD) is soliciting proposals for small molecule drug candidates for treatment of or prevention against alphavirus-induced ...
The Defense Threat Reduction Agency (DTRA) Research and Development Enterprise Chemical and Biological Technologies Directorate (RD-CB) continues the effort towards ...
MediVector, Inc., a privately held drug development company in Boston, is being awarded a $138,500,000 contract under a DoD Joint ...
The Defense Threat Reduction Agency (DTRA) intends to award a sole source contract to Global Viral Forecasting, Inc. (GVF) to ...
George Mason University (GMU) has been awarded a $7.6M contract for translational peptide research and development by the Defense Threat ...
The Defense Threat Reduction Agency (DTRA) has renewed a Broad Agency Announcement (BAA) to support Counter Weapons of Mass Destruction ...